Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Texas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Texas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Texas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Rishabh Date (NPI 1295154938)

Field	Value
Entity Type	Individual
Organization	Rishabh Date
Address	4460 Bissonnet St Ste 200
City	Bellaire
State	TX
ZIP	77401
Taxonomy	Ophthalmology Physician
NPI Enumerated	April 9, 2014

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider is effectively Medicare-centered: reported Total Medicare revenue is $2.9M while there is no Medicaid billing on file, and the NPI has been enumerated since 2014-04-09 (~12 years ago). The absence of Medicaid activity indicates a single-payer revenue profile concentrated in the Medicare population, which shapes both patient mix and payer risk exposure.

Revenue is highly concentrated in a small set of codes: the precomputed top 3 Medicare codes by revenue account for 68.8% of this provider's total Medicare revenue, driven primarily by J0178 at 47.8%, J2778 at 12.4%, and 92014 at 8.7%. This concentration means a large share of income depends on anti-VEGF drug administration and established comprehensive ophthalmology visits.

The code mix indicates a retina-focused ophthalmology operation: high-volume drug codes J0178 (aflibercept) and J2778 (ranibizumab), together with intravitreal injection procedure 67028, point to routine in-office anti-VEGF therapy. Complementary imaging and examination codes such as 92134 (retinal imaging) and 92202/92201 (extended ophthalmoscopy) further support a practice organized around medical retina diagnostics and frequent follow-up of chronic retinal disease.

Despite the dominance of anti-VEGF revenue, the provider’s injection volumes are typical rather than dominant nationally: J0178 ranks #512 of 3204 providers nationally (84th percentile; typical, unremarkable volume for this code), J2778 ranks #215 of 1208 providers nationally (82th percentile; typical, unremarkable volume for this code), and J2777 ranks #1186 of 2039 providers nationally (42th percentile; typical, unremarkable volume for this code). These percentiles suggest the practice delivers substantial injection therapy but is not a national outlier for biologic injection volumes.

In contrast, the provider is an extreme outlier on several exam and imaging metrics, signaling unusually high clinical throughput: 92014 ranks #135 of 35415 providers nationally (100th percentile; extreme outlier, far above typical national volume), 92134 ranks #635 of 26868 providers nationally (98th percentile; extreme outlier, far above typical national volume), and 92202 ranks #44 of 2327 providers nationally (98th percentile; extreme outlier, far above typical national volume). Those rankings indicate this provider sees far more established comprehensive exams and retinal imaging than most peers, consistent with a high-volume outpatient clinic managing many follow-ups.

Procedure-level coding aligns with the injection and clinic workflow: 67028 (intravitreal injection) shows 1.8K claims and $184.1K revenue (6.3% of Medicare revenue) and ranks #519 of 4255 providers nationally (88th percentile; typical, unremarkable volume for this code), reinforcing that in-office injection procedures are a major operational activity. Smaller but present categories such as J3590 and J3490 (unclassified biologics/drugs) contribute meaningful single-code revenue ($108.1K and $88.5K respectively) but do not dominate the overall profile.

The provider’s payer mix and revenue concentration create business implications: with $2.9M concentrated in Medicare and no Medicaid billing on file, reimbursement exposure and growth depend heavily on Medicare policy and anti-VEGF drug reimbursement dynamics. Strategic decisions about drug selection, buy-and-bill practice, and capacity for imaging and injection throughput will materially affect revenue stability given that the top three codes represent 68.8% of Medicare revenue.

An additional operational signal comes from high new-patient E/M reporting: 99204 has 240 claims and $31.9K revenue (1.1% of Medicare revenue) and ranks #2768 of 227068 providers nationally (99th percentile; extreme outlier, far above typical national volume). This suggests the practice also handles a notable volume of complex new patient evaluations, which may reflect referral intake for retinal or complex ophthalmic disease alongside high follow-up volumes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,060	$680	$1.4M
J2778	Injection, ranibizumab, 0.1 mg	2,010	$180	$361.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,460	$100	$255.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	7,860	$30	$220.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,810	$100	$184.1K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	650	$210	$138.4K
J3590	Unclassified biologics	50	$2,250	$108.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,560	$40	$89.5K
J3490	Unclassified drugs	50	$1,840	$88.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	240	$130	$31.9K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Texas Distribution

Rishabh Date — 4 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Texas

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	13	210	610	$690	$694.9K
J2777	38	140	7,470	$30	$479.2K
J2778	18	80	630	$180	$345.3K
Q5128	14	50	770	$220	$263.7K
J3590	6	40	70	$1,640	$162.7K
67028	20	290	510	$90	$73K
J3490	41	350	60	$480	$54.4K
92235	39	160	60	$100	$21.3K
92014	1	2,700	100	$80	$21K
J7999	3	140	90	$80	$14.4K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Rishabh Date, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
Charles Wykoff	TX	Ophthalmology Physician	$6.2M	$0
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Matthew Benz	TX	Ophthalmology Physician	$5.7M	$0
David Brown	TX	Ophthalmology Physician	$5.7M	$0
Richard Lane	TX	Retina Specialist (Ophthalmology) Physician	$4.8M	$0
Tien Wong	TX	Ophthalmology Physician	$4.5M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sumit Shah	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Newman Sund	MD	Ophthalmology Physician	$4M	$0

Nearby Providers

Other providers in the same ZIP code as Rishabh Date, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kingsley Home Care Inc	TX	Home Health Agency	$0	$22.7M
Adaku Iwu	TX	Family Nurse Practitioner	$3.3M	$0
Emmanuel Chang	TX	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Arash Kimyai-asadi	TX	MOHS-Micrographic Surgery Physician	$2.2M	$0
Leonard Goldberg	TX	MOHS-Micrographic Surgery Physician	$2.1M	$0
Paul Stewart	TX	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
Effie Rahman	TX	Ophthalmology Physician	$2M	$0
Kenneth Fan	TX	Ophthalmology Physician	$2M	$0
Linsey Ittyipe	TX	Family Nurse Practitioner	$1.2M	$0
Courtney Fuller	TX	Family Nurse Practitioner	$1.1M	$0

Rishabh Date — Billing Profile & Reimbursement Data

Sign up for Rishabh Date — Billing Profile & Reimbursement Data policy alerts

Rishabh Date — Billing Profile & Reimbursement Data

Sign up for Rishabh Date — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References